Pharmagen Accounts Payable vs Inventory Analysis
| PHRX Stock | USD 0.0001 0.00 0.00% |
Pharmagen financial indicator trend analysis is much more than just breaking down Pharmagen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pharmagen is a good investment. Please check the relationship between Pharmagen Accounts Payable and its Inventory accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.
Accounts Payable vs Inventory
Accounts Payable vs Inventory Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pharmagen Accounts Payable account and Inventory. At this time, the significance of the direction appears to have strong relationship.
The correlation between Pharmagen's Accounts Payable and Inventory is 0.79. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Inventory in the same time period over historical financial statements of Pharmagen, assuming nothing else is changed. The correlation between historical values of Pharmagen's Accounts Payable and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Pharmagen are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Accounts Payable i.e., Pharmagen's Accounts Payable and Inventory go up and down completely randomly.
Correlation Coefficient | 0.79 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Pharmagen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Pharmagen are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Inventory
Most indicators from Pharmagen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pharmagen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmagen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.Selling General Administrative is likely to rise to about 6.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.53 in 2024.
| 2012 | 2013 | 2023 | 2024 (projected) | Gross Profit | 1.3M | 3.0M | 3.5M | 3.7M | Total Revenue | 4.3M | 4.8M | 5.5M | 5.8M |
Pharmagen fundamental ratios Correlations
Click cells to compare fundamentals
Pharmagen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pharmagen Stock Analysis
When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.